Skip to content
Magrolimab
Magrolimab is an antibody pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
31 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Myeloid leukemia acuteD015470C92.042217
Myelodysplastic syndromesD009190D462113
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369C80223
Urologic neoplasmsD014571C64-C68212
Colorectal neoplasmsD015179122
Non-hodgkin lymphomaD008228C85.9212
Urinary bladder neoplasmsD001749C67111
Sezary syndromeD012751C84.1111
Mycosis fungoidesD009182C84.0111
Hodgkin diseaseD006689C8111
Squamous cell carcinoma of head and neckD00007719511
Multiple myelomaD009101C90.011
Show 1 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Ovarian neoplasmsD010051EFO_0003893C5611
Hematologic neoplasmsD01933711
NeuroblastomaD009447EFO_000062111
OsteosarcomaD01251611
B-cell chronic lymphocytic leukemiaD015451C91.111
Follicular lymphomaD008224C8211
Mantle-cell lymphomaD020522C83.111
B-cell lymphomaD01639311
Large b-cell lymphoma diffuseD016403C83.311
Brain neoplasmsD001932EFO_0003833C7111
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameMAGROLIMAB
INNmagrolimab
Description
Magrolimab is an antibody pharmaceutical. It is currently being investigated in clinical studies.
Classification
Antibody
Drug classmonoclonal antibodies
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL IDCHEMBL4297985
ChEBI ID
PubChem CID
DrugBank
UNII ID90YIEHRFJ9 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 393 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
11 adverse events reported
View more details